MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    PREVALENCE OF MOVEMENT DISORDERS AT A TERTIARY HEALTH CARE CENTRE IN ABUJA, NIGERIA

    N. Obianozie, G. Onwuegbuzie, P. Alabi, F. Abdulai (Gwagwalada, Nigeria)

    Objective: This study aims to describe the prevalence and sociodemographic characteristics of movement disorders seen at our Specialised Movement Disorder (MD) clinic at Abuja, Nigeria…
  • MDS Virtual Congress 2021

    Functional neurological symptoms as initial presentation of Creutzfeldt-Jacob Disease: case series.

    V. Gómez-Mayordomo, M. Kojovic, E. López-Valdés, F. Alonso-Frech, A. Horga-Hernández, R. Fernández-Rodríguez, I. Pareés (Madrid, Spain)

    Objective: To describe a clinical series of three patients who presented positive signs of a Functional Movement Disorder (FMD) at the onset of a sporadic…
  • MDS Virtual Congress 2021

    New presenilin-1 missense variant (p.Pro88Arg) characterized by initial progressive supranuclear palsy like phenotype.

    Q. Thomas, S. Nambot, C. Thauvin-Robinet, C. Philippe, Y. Bejot, G. Dupont (Dijon, France)

    Objective: To report a new presenilin-1 (PSEN 1) missense variant (p.Pro88Arg) characterized by initial Progressive Supranuclear Palsy (PSP) like phenotype. Background: Pathogenic variants in the PSEN1gene…
  • MDS Virtual Congress 2021

    DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

    I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)

    Objective: The aim of this study was to evaluate the DNA methylation of the CDKN2B/CDKN2B-AS1 enhancer with Huntington's disease and lung cancer. Background: Phenomenon of…
  • MDS Virtual Congress 2021

    Quantifying Tremor in the R6/2 Mouse model of Huntington’s Diease

    H. Skelton, D. Grogan, J. Rubiano, R. Gross, C. Gutekunst (Atlanta, USA)

    Objective: To better characterize and precisely quantify the tremor widely observed in R6/2 mouse models of Huntington’s disease. Background: Tremor is a prominent feature of…
  • MDS Virtual Congress 2021

    Detection of silent periods of muscle activity related to negative myoclonia

    A. Sinokki, S. Rissanen, J. Hyppönen, K. Silvennoinen, L. Säisänen, P. Karjalainen, E. Mervaala, R. Kälviäinen (Kuopio, Finland)

    Objective: The aim of the study was to determine if home-monitoring of surface electromyography (EMG) can be used to detect silent periods of muscle activity…
  • MDS Virtual Congress 2021

    Role of Selective Serotonin Reuptake Inhibitors in the Management of Motor Tics in Tourette’s Syndrome

    A. Armas-Salazar, J. Ortega-Márquez, D. Sandoval-Lopez, G. Pérez-Plascencia, C. Ortéga-Arenas, D. Chapa-Juárez (Ciudad de México, Mexico)

    Objective: Determine the usefulness of paroxetine in terms of motor and behavioral manifestations control in a patient with Tourrete Syndrome (TS) with intolerance to dopamine…
  • MDS Virtual Congress 2021

    Spinal Excitability and Plasticity in Hereditary Spastic Paraparesis: A Neurophysiological Study

    A. Zampogna, A. Guerra, F. Asci, A. Funcis, C. Celletti, F. Camerota, A. Berardelli, A. Suppa (Rome, Italy)

    Objective: To investigate spinal excitability and plasticity in patients with pure hereditary spastic paraparesis (HSP). Background: Pure HSP (SPG4) is a neurodegenerative disorder characterized by…
  • MDS Virtual Congress 2021

    Safety of MRI performed with leads-only or fully implanted DBS system

    J. Wilden, C. Torres Diaz, S. Groppa, D. Gaudin, E. Hargreaves, D. Vansickle, P. Slotty, A. Gharabaghi, E. Jiltsova, S. Ojemann, J. Aldred, S. Redding, D. Weiss, F. Defresne, E. Karst, B. Cheeran, R. Gross (Shrevport, USA)

    Objective: To support the safety of the Infinity DBS system with MR Conditional labeling. Background: An international, multicenter, observational, prospective, single-arm, post-market clinical follow-up study…
  • MDS Virtual Congress 2021

    Evaluating Patients’ Preferences for Parkinson’s Disease Treatments

    M. Serbin, J. Sutphin, C. Leach, C. Mansfield, C. Yonan, O. Klepitskaya, M. Sheehan, A. Donnelly (San Diego, USA)

    Objective: To identify patients’ preferences for attributes of oral medications that are added to levodopa or levodopa/carbidopa (LD/CD) regimens to reduce OFF-time for Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley